Trinity Biotech plc Sponsored ADR
Trinity Biotech is a science and technology company with a well-established foundation in high-quality laboratory and point-of-care diagnostics, now repositioning to pursue opportunities in advanced measurement, analytical science, and data-driven systems as it helps bridge the p
Investor website: https://trinitybiotech.com/
About
Trinity Biotech is a science and technology company with a well-established foundation in high-quality laboratory and point-of-care diagnostics, now repositioning to pursue opportunities in advanced measurement, analytical science, and data-driven systems as it helps bridge the physical-to-digital gap in an increasingly AI-driven world. The company has developed and commercialized trusted diagnostic solutions built on deep expertise in assay development, biosensing, analytical chemistry, and regulated manufacturing. Its product portfolio includes the FDA 510(k) cleared Premier Hb9210™ HbA1c analyzer, the Premier Resolution system for haemoglobin variant detection, and various rapid tests for HIV and autoimmune diseases. Trinity Biotech is focusing on innovation in biosensors and mass spectrometry-based solutions, leveraging its capabilities in high-performance detection technologies to participate in markets shaped by automation and real-time analytics.
Verified company data
- Leadership
- John Gillard (CEO, Joined Trinity Biotech in November 2020 as CFO and Secretary to the Board. Appointed CEO and President in December 2023. Chartered Accountant and Chartered Tax Advisor with experience at Alphabet Inc./Google and ION Investment Group.), Ronan O’Caoimh (Director, Co-founded Trinity Biotech in June 1992 and served as CFO until March 1994, then CEO until October 2022. Former Managing Director of Noctech Limited.), Andrew Omidvar Ph.D., MBA (Board Member, Joined in December 2023 with over 25 years of experience in technology solutions in various industries. Former Vice President of Government R&D and Enterprise for Philips.), Paul Tivnan (Director, Over 25 years of leadership experience in finance and corporate governance. Currently CFO of Deriva Energy LLC and previously held CFO roles at Brookfield Renewable Ireland and Ardmore Shipping Corporation.)
Verified data last updated:
Recent filings
- Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 · trib_2026-09-09_11-35-03.pdf
- Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 · trib_2026-09-08_20-00-17.pdf
- Notice of Effectiveness · trib_2026-09-02_03-15-17.pdf
- Post-Effective amendments for registration statement · trib_2026-08-28_19-17-50.pdf
- Amendment Withdrawal Request · trib_2026-08-27_19-39-24.pdf
- [Amend] Registration statement for certain foreign private issuers · trib_2026-08-21_17-27-32.pdf
- Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 · trib_2026-08-17_11-32-09.pdf
- Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 · trib_2026-08-14_13-08-49.pdf